生长抑素通过调节巨噬细胞活动改善干眼病角膜神经异常与炎症
研究在泪腺切除诱导的干眼病小鼠模型中评估帕瑞肽(SOM230)对 corneal nerve abnormalities 的治疗作用及机制。SOM230 治疗显著改善角膜上皮完整性、减少疼痛行为并恢复角膜敏感性,RNA 测序显示其下调 TNF-α 和 NF-κB 等炎症通路,流式细胞术和免疫荧光显示其减少促炎 M1 巨噬细胞并增加抗炎 M2 巨噬细胞。结论认为 SOM230 通过抑制炎症通路和促进巨噬细胞从 M1 向 M2 极化转变来缓解干眼病神经异常,提示调节巨噬细胞极化是其治疗作用的关键机制。
要点
- SOM230 改善干眼病小鼠角膜上皮完整性、减少疼痛行为并恢复角膜敏感性。
- SOM230 下调 TNF-α 和 NF-κB 等关键炎症通路。
- SOM230 减少促炎 M1 巨噬细胞并增加抗炎 M2 巨噬细胞。
核心结论
- SOM230 通过抑制炎症通路(TNF-α、NF-κB)和促进巨噬细胞从促炎 M1 表型向修复性 M2 表型转变,缓解干眼病中的神经异常。
- 调节巨噬细胞极化是 SOM230 治疗作用的关键机制,提示其作为干眼病神经损伤治疗策略的潜力。
研究设计与样本
- 研究采用雄性 C57BL/6J 小鼠行泪腺切除术诱导干眼病模型,并给予 SOM230 或 PBS 治疗。
- 评估指标包括角膜上皮完整性、疼痛相关行为和角膜敏感性。
- 采用 RNA 测序鉴定 SOM230 调节的潜在通路,并用流式细胞术和免疫荧光定量巨噬细胞极化状态。
主要发现
- 与 PBS 相比,SOM230 治疗显著改善角膜上皮完整性、减少疼痛行为并恢复角膜敏感性。
- RNA 测序显示 SOM230 下调 TNF-α 和 NF-κB 等关键炎症通路。
- 流式细胞术和免疫荧光显示 SOM230 减少促炎 M1 巨噬细胞并增加抗炎 M2 巨噬细胞,从而减轻角膜炎症并改善愈合。
临床怎么用
- 原文结论指出 SOM230 具有作为干眼病神经损伤治疗策略的潜力。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study aimed to investigate the therapeutic effects of pasireotide (SOM230) on corneal nerve abnormalities in a mouse model of dry eye disease (DED) and to elucidate its potential mechanisms of action. METHODS: Male C57BL/6J mice underwent lacrimal gland excision (LGE) to induce DED and were treated with SOM230 or PBS. Corneal epithelial integrity, pain-related behaviors, and corneal sensitivity were evaluated. RNA sequencing was performed to identify potential pathways modulated by SOM230. Flow cytometry and immunofluorescence quantified macrophage polarization states. RESULTS: SOM230 treatment significantly improved corneal epithelial integrity, reduced pain behaviors, and restored corneal sensitivity compared to PBS. RNA sequencing revealed that SOM230 downregulated key inflammatory pathways, including TNF-α and NF-κB. Flow cytometry and immunofluorescence showed that SOM230 modulated macrophage polarization by decreasing pro-inflammatory M1 macrophages and enhancing anti-inflammatory M2 macrophages, contributing to reduced corneal inflammation and improved healing. CONCLUSIONS: SOM230 alleviates nerve abnormalities in DED by suppressing inflammatory pathways (TNF-α, NF-κB) and promoting a shift in macrophage polarization from the pro-inflammatory M1 phenotype to the reparative M2 phenotype. These findings suggest that modulation of macrophage polarization is a crucial mechanism underlying the therapeutic effects of SOM230, highlighting its potential as a treatment strategy for nerve damage in DED.
引用
- Zhu X, Ye H, Lu Y, et al. Somatostatin Ameliorates Corneal Nerve Abnormalities and Inflammation Through Regulation of Macrophage Activities in Dry Eye Disease. Invest Ophthalmol Vis Sci. 2025. PMID: 41201292. doi:10.1167/iovs.66.14.18
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。